Show simple item record

dc.contributor.authorSingh, N
dc.contributor.authorThet, Z
dc.contributor.authorHan, T
dc.contributor.authorHan, C
dc.contributor.authorMartin, JA
dc.date.accessioned2021-05-18T05:39:29Z
dc.date.available2021-05-18T05:39:29Z
dc.date.issued2018
dc.identifier.issn1320-5358en_US
dc.identifier.urihttp://hdl.handle.net/10072/404479
dc.description.abstractBackground Post transplant diarrhoea is a frequent complication and aetiological diagnosis can be challenging. Microsporidia, obligate intracellular parasitic fungi, primarily cause infection in HIV patients, although several case reports have sited it as an opportunistic infection in transplant recipients. Case Report A 58‐year old patient, two years post deceased donor renal transplant, presented with one week’s history of severe diarrhoea >10/day without any systemic symptoms. CMV status indicated both donor and recipient were positive. The immunosuppressive regimen included tacrolimus, mycophenolate mofetil and prednisolone. Differential diagnosis included infectious aetiology, mycophenolate associated or CMV colitis. Initial evaluation showed preserved graft function, normal inflammatory markers, target range tacrolimus level and negative faecal assay for routine bacterial and parasitic pathogens. The dose of mycophenolate was adjusted and symptoms resolved transiently with conservative management. He re‐presented 10 days later with recurrence of diarrhoea. On further testing, stool PCR for Microsporidia species was found to be positive. The quantitative serum PCR assay showed CMV DNA was negative. Immunohistochemistry for CMV was negative in colon and gastric biopsies. Duodenal and ileal biopsies showed parasitophorous vesicles containing finely granular eosinophilic structures suspicious for microsporidia. The endoscopy findings regarding microsporidia were considered equivocal and the diarrhoea had been ongoing for nearly 4 weeks. Within 48 h of commencing Albendazole 400 mg, the symptoms improved remarkably, hence the treatment was continued for one month. No microsporidia was seen in subsequent stool examinations. Conclusion Studies have suggested exposure to animal excreta, ingestion or inhalation of spores as risks; however, in our patient no specific factors were identified. Our case reinforces that Microsporidia should be considered in assessment of renal transplant recipients presenting with persistent diarrhoea.en_US
dc.languageEnglishen_US
dc.publisherWileyen_US
dc.publisher.urihttps://onlinelibrary.wiley.com/doi/10.1111/nep.13442en_US
dc.relation.ispartofconferencename54th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN)en_US
dc.relation.ispartofconferencetitleNephrologyen_US
dc.relation.ispartofdatefrom2018-09-08
dc.relation.ispartofdateto2018-09-12
dc.relation.ispartoflocationSydney, Australiaen_US
dc.relation.ispartofpagefrom97en_US
dc.relation.ispartofpageto97en_US
dc.relation.ispartofissueS3en_US
dc.relation.ispartofvolume23en_US
dc.subject.fieldofresearchClinical Sciencesen_US
dc.subject.fieldofresearchcode1103en_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsLife Sciences & Biomedicineen_US
dc.subject.keywordsUrology & Nephrologyen_US
dc.titleA case of intestinal microsporiodosis in renal transplant recipient: albendazole is effectiveen_US
dc.typeConference outputen_US
dc.type.descriptionE3 - Conferences (Extract Paper)en_US
dcterms.bibliographicCitationSingh, N; Thet, Z; Han, T; Han, C; Martin, JA, A case of intestinal microsporiodosis in renal transplant recipient: albendazole is effective, Nephrology, 2018, 23, pp. 97-97en_US
dc.date.updated2021-05-18T05:37:42Z
gro.hasfulltextNo Full Text
gro.griffith.authorThet, Zaw


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record